
Cica: Used in soothing moisturizers; ingredient-specific clinical evidence is limited. Polyhydroxy Acids: Offers exfoliation through ingredients such as gluconolactone and lactobionic acid.


Consider for a gentle moisturizer; check the complete formula and your tolerance.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
Can you use both?
A gentle pairing for sensitive skin: PHAs exfoliate lightly, cica calms.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Contains plant compounds: Extracts may include madecassoside and related molecules. Repair signaling is being studied: Laboratory findings do not guarantee clinical repair.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation. Some illustrated pathways are experimental; laboratory findings do not establish a clinical treatment benefit.

Loosens surface cells: PHAs promote shedding in the outer skin. Helps bind water: Hydroxyl groups contribute to water binding.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Cica usually means Centella asiatica extract, a mixture whose composition varies with extraction and standardization. There is no established percentage scale that makes different cica products equally potent.
Choosing a strength: Check whether the label names whole Centella extract, madecassoside, asiaticoside, or another purified compound.
Higher strengths: A higher extract percentage does not necessarily mean more of the compounds studied in clinical research.
Formula matters: A study of 0.1% madecassoside with 5% vitamin C cannot be used as a recommended percentage for whole cica extract.
PHA is a family name, not one ingredient or one standard strength. A clinical acne trial used 14% gluconolactone; that result cannot be transferred directly to lactobionic acid or mixed-PHA products.
14%
Studied gluconolactone lotion
An older controlled acne trial tested this specific formula. It does not establish the best percentage for all PHA skincare.
Choosing a strength: Check which PHA is listed, whether the product stays on or washes off, and whether it also contains other exfoliating acids.
Higher strengths: A PHA product can still irritate, particularly when combined with other acids. A high total-acid percentage is not a validated benefit rating.
Formula matters: The individual acid, acidity and base formula matter. A blended-acid percentage does not reveal the amount of each PHA.
Approximate windows, not promises.
First few weeksSkin may feel softer soon after use; relief depends on the formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksJudge hydration, comfort and whether dryness is recurring.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksPersistent cracking, itch or a rash needs reassessment.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsContinue if comfortable; hydration usually requires ongoing use.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsMoisturizing does not establish reversal of structural ageing or scars.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Can cause a contact rash; avoid assuming botanical products are allergy-free.
Can still sting or cause a rash; sensitive skin does not guarantee tolerance.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Applied to the skin, very little is expected to be absorbed, but ask the doctor managing your pregnancy. Mention it separately if you also take gotu kola by mouth.
Low-strength leave-on acids are generally considered acceptable; ask the clinician managing your pregnancy.
On the skin. The finished product delivers cica in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Contains plant compounds studied for inflammatory and repair signalling; extracts are not chemically identical.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers polyhydroxy acids in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. PHA ingredients promote surface exfoliation and may also bind water; individual acids and formulas differ.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider for a gentle moisturizer; check the complete formula and your tolerance.
A 20-person study tested madecassoside together with vitamin C for six months. It cannot isolate Centella extract or establish treatment of acne, eczema or scars.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
A 150-person trial tested 14% gluconolactone for acne. Evidence from that molecule or a mixed-acid serum does not establish identical effects for all PHAs.
Sources